|
Market Cap (5-Jun) $23,964,560 (896th) |
Close (30-Jun) $0.043 |
Volume (30-Jun) 1,415,719 |
Shortsold (5-Nov) 11,657 (0.00%) (566th) |
|
52w High $0.135 |
52w Low $0.043 |
P/E - |
EPS -0.02 |
NOX released this announcement to the ASX on 7 June 2022, 8:44. The announcement is not marked as price sensitive, and is 26 page(s) in length and 1.86MB in size.
You can view all announcements from NOX and see how they appear on a price chart on the announcements page.
At the date of this announcement, NOX was 0.359% short sold according to ASIC data. It was ranked the 369th most shorted stock on the ASX. It remains ranked 566th as of the latest reported data (05 November 2025).
| Other Recent Announcements from NOX | |
|---|---|
| Change of Director's Interest Notice - FB | 29 June 2023, 12:08 |
| Change of Director's Interest Notice - FB | 19 June 2023, 19:08 |
| Change of Director's Interest Notice - BP | 19 June 2023, 19:08 |
| Noxopharm Corporate Presentation | 7 June 2022, 8:44 |
| Veyonda Abstract Published at ASCO Annual Meeting 2022 | 27 May 2022, 8:22 |
| March 2022 Quarterly Activities Report and Appendix 4C | 28 April 2022, 8:23 |
| Orphan Drug Designation Granted to Noxopharm by US FDA | 22 March 2022, 8:38 |
You must be logged in to post a reply.
Noxopharm 